W Liu1, Y Liu, Y Yang, W Ou, X Chen, B Huang, H Wang, M Liu. 1. Prof. Meilin Liu, Department of Geriatrics, Peking University First Hospital; No. 8 Xishiku Street, Xicheng District, Beijing 100034, China, E-mail address: liumeilin@hotmail.com.
Abstract
BACKGROUND: Aging is an acknowledged risk factor for most chronic diseases and functional impairments. The practicability of potential biomarkers of aging remains unsure. Moreover, biomarkers related to certain geriatric diseases, such as carotid atherosclerosis and multiple co-morbidities are less understood. The purpose of this study was to investigate the definite relationship between metabolic biomarkers and aging-related diseases. METHODS: Eighty-five male adults aged fifty years or older from the general population were enrolled. Plasma metabolic biomarkers, including fourteen amino acids and thirty-six acylcarnitines, were measured by liquid chromatography mass spectrometry. Bivariate correlation analysis was employed to estimate the correlations between variables and age, and also to evaluate the relationship between metabolic biomarkers and aging-related diseases. Receiver operating characteristic (ROC) curve was conducted to judge the diagnostic efficiency of potential metabolic biomarkers for co-morbidities. RESULTS: Certain metabolic biomarkers were strongly positively correlated with age, such as tetradecenoylcarnitine (C14:1), microalbumin-urine creatinine ratio (UACR), dodecenoylcarnitine (C12:1) and citrulline (p < 0.001). Carotid atherosclerosis and co-morbidities were positively correlated with aging (p < 0.001). After adjustment for age, hydroxytetradecanoylcarnitine (C14OH) remained positively correlated with carotid plague area. Besides, citrulline had diagnostic power for co-morbidities. CONCLUSIONS: Citrulline may be a promising metabolic biomarker in the middle-aged and elderly men. Larger-scale and long-term studies are needed to confirm our findings.
BACKGROUND: Aging is an acknowledged risk factor for most chronic diseases and functional impairments. The practicability of potential biomarkers of aging remains unsure. Moreover, biomarkers related to certain geriatric diseases, such as carotid atherosclerosis and multiple co-morbidities are less understood. The purpose of this study was to investigate the definite relationship between metabolic biomarkers and aging-related diseases. METHODS: Eighty-five male adults aged fifty years or older from the general population were enrolled. Plasma metabolic biomarkers, including fourteen amino acids and thirty-six acylcarnitines, were measured by liquid chromatography mass spectrometry. Bivariate correlation analysis was employed to estimate the correlations between variables and age, and also to evaluate the relationship between metabolic biomarkers and aging-related diseases. Receiver operating characteristic (ROC) curve was conducted to judge the diagnostic efficiency of potential metabolic biomarkers for co-morbidities. RESULTS: Certain metabolic biomarkers were strongly positively correlated with age, such as tetradecenoylcarnitine (C14:1), microalbumin-urine creatinine ratio (UACR), dodecenoylcarnitine (C12:1) and citrulline (p < 0.001). Carotid atherosclerosis and co-morbidities were positively correlated with aging (p < 0.001). After adjustment for age, hydroxytetradecanoylcarnitine (C14OH) remained positively correlated with carotid plague area. Besides, citrulline had diagnostic power for co-morbidities. CONCLUSIONS:Citrulline may be a promising metabolic biomarker in the middle-aged and elderly men. Larger-scale and long-term studies are needed to confirm our findings.
Authors: Alexander Bürkle; María Moreno-Villanueva; Jürgen Bernhard; María Blasco; Gerben Zondag; Jan H J Hoeijmakers; Olivier Toussaint; Beatrix Grubeck-Loebenstein; Eugenio Mocchegiani; Sebastiano Collino; Efstathios S Gonos; Ewa Sikora; Daniela Gradinaru; Martijn Dollé; Michel Salmon; Peter Kristensen; Helen R Griffiths; Claude Libert; Tilman Grune; Nicolle Breusing; Andreas Simm; Claudio Franceschi; Miriam Capri; Duncan Talbot; Paola Caiafa; Bertrand Friguet; P Eline Slagboom; Antti Hervonen; Mikko Hurme; Richard Aspinall Journal: Mech Ageing Dev Date: 2015-03-24 Impact factor: 5.432
Authors: Charalambos Vlachopoulos; Panagiotis Xaplanteris; Victor Aboyans; Marianne Brodmann; Renata Cífková; Francesco Cosentino; Marco De Carlo; Augusto Gallino; Ulf Landmesser; Stéphane Laurent; John Lekakis; Dimitri P Mikhailidis; Katerina K Naka; Athanasios D Protogerou; Damiano Rizzoni; Arno Schmidt-Trucksäss; Luc Van Bortel; Thomas Weber; Akira Yamashina; Reuven Zimlichman; Pierre Boutouyrie; John Cockcroft; Michael O'Rourke; Jeong Bae Park; Giuseppe Schillaci; Henrik Sillesen; Raymond R Townsend Journal: Atherosclerosis Date: 2015-05-16 Impact factor: 5.162
Authors: Vincent M van Deursen; Renato Urso; Cecile Laroche; Kevin Damman; Ulf Dahlström; Luigi Tavazzi; Aldo P Maggioni; Adriaan A Voors Journal: Eur J Heart Fail Date: 2013-12-19 Impact factor: 15.534
Authors: Carmen Martin-Ruiz; Carol Jagger; Andrew Kingston; Joanna Collerton; Michael Catt; Karen Davies; Mick Dunn; Catharien Hilkens; Bernard Keavney; Simon H S Pearce; Wendy P J den Elzen; Duncan Talbot; Laura Wiley; John Bond; John C Mathers; Martin P Eccles; Louise Robinson; Oliver James; Thomas B L Kirkwood; Thomas von Zglinicki Journal: Mech Ageing Dev Date: 2011-08-16 Impact factor: 5.432
Authors: Leslie A Consitt; Timothy R Koves; Deborah M Muoio; Masato Nakazawa; Christopher A Newton; Joseph A Houmard Journal: Biochem Biophys Res Commun Date: 2016-09-28 Impact factor: 3.575
Authors: Christopher B Newgard; Jie An; James R Bain; Michael J Muehlbauer; Robert D Stevens; Lillian F Lien; Andrea M Haqq; Svati H Shah; Michelle Arlotto; Cris A Slentz; James Rochon; Dianne Gallup; Olga Ilkayeva; Brett R Wenner; William S Yancy; Howard Eisenson; Gerald Musante; Richard S Surwit; David S Millington; Mark D Butler; Laura P Svetkey Journal: Cell Metab Date: 2009-04 Impact factor: 27.287
Authors: Daniela Haase; Laura Bäz; Marcus Franz; P Christian Schulze; Tarek Bekfani; Sophie Neugebauer; Michael Kiehntopf; Sven Möbius-Winkler Journal: Clin Res Cardiol Date: 2020-10-14 Impact factor: 5.460